购物车
您的购物车当前为空
PROTAC CCR9 Degrader 1 是一种专门靶向CCR9的PROTAC类降解剂。它通过招募VHL E3连接酶,诱导CCR9的泛素化和蛋白酶体降解,从而降低细胞内的CCR9水平。其对人源CCR9的Ki值为78.0 nM,并能通过结合CCR9的细胞内变构结合位点调节GPCR活性。PROTAC CCR9 Degrader 1 可用于克罗恩病的研究。
PROTAC CCR9 Degrader 1 是一种专门靶向CCR9的PROTAC类降解剂。它通过招募VHL E3连接酶,诱导CCR9的泛素化和蛋白酶体降解,从而降低细胞内的CCR9水平。其对人源CCR9的Ki值为78.0 nM,并能通过结合CCR9的细胞内变构结合位点调节GPCR活性。PROTAC CCR9 Degrader 1 可用于克罗恩病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | PROTAC CCR9 Degrader 1 is a PROTAC-based degrader specifically targeting CCR9. It functions by recruiting the VHL E3 ligase, leading to the ubiquitination and proteasomal degradation of CCR9, thereby reducing its intracellular levels. The compound has a Ki value of 78.0 nM for human CCR9. Additionally, PROTAC CCR9 Degrader 1 modulates GPCR activity by binding to the allosteric site within CCR9 and is applicable in research related to Crohn's disease. |
| 靶点活性 | CCR9:78.0 nM (Ki) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多